Bayesian Capital Management’s Compugen CGEN Stock Holding History

Bayesian Capital Management’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18,250	Closed	-$59K	–	813
2022 Q1	$59K	Buy	+18,250	New	+$61.6K	0.01%	724
2020 Q4	–	Sell	-10,244	Closed	-$166K	–	475
2020 Q3	$166K	Buy	+10,244	New	+$168K	0.04%	455

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Bayesian Capital Management's CGEN Position: Q2 2022 in Review

Bayesian Capital Management sold out of Compugen (CGEN) in Q2 2022, closing a stake of 18,250 shares — an estimated $59K sold.

Bayesian Capital Management first reported a position in CGEN in Q3 2020 and held it in 2 quarters. The position peaked at $166K in Q3 2020. 89 funds tracked by Wall St. Rank hold CGEN as of Q2 2022.

Bayesian Capital Management reported no remaining Compugen position as of Q2 2022 after selling out during the quarter.
Bayesian Capital Management sold 18,250 Compugen shares in Q2 2022, an estimated $59K.
Bayesian Capital Management first reported a position in Compugen in Q3 2020 and held it in 2 quarters.
Bayesian Capital Management's Compugen position peaked at $166K in Q3 2020.
89 funds tracked by Wall St. Rank held Compugen as of Q2 2022.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.